BIOMARKERS TO DETECT CENTRAL DOPAMINE DEFICIENCY AND DISTINGUISH PARKINSON DISEASE FROM MULTIPLE SYSTEM ATROPHY

OBJECTIVE: Biomarkers are increasingly important to diagnose and test treatments of neurodegenerative diseases such as Parkinson disease (PD). This study compared neuroimaging, neurochemical, and olfactory potential biomarkers to detect central dopamine (DA) deficiency and distinguish PD from multip...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Goldstein, David S., Holmes, Courtney, Bentho, Oladi, Sato, Takuya, Moak, Jeffrey, Sharabi, Yehonatan, Imrich, Richard, Conant, Shielah, Eldadah, Basil A.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2650101/
https://ncbi.nlm.nih.gov/pubmed/18325818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2008.01.010
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires